Cargando…
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells
Residual cancer cells that survive upfront drug treatments act as a reservoir from which eventual resistant disease emerges. Although there is great interest in therapeutically targeting residual cells, efforts to do so are hampered by our limited knowledge of the vulnerabilities existing in this ce...
Autores principales: | Ali, Moiez, Lu, Min, Ang, Hazel Xiaohui, Soderquist, Ryan S., Eyler, Christine E., Hutchinson, Haley M., Glass, Carolyn, Bassil, Christopher F., Lopez, Omar M., Kerr, D. Lucas, Falcon, Christina J., Yu, Helena A., Hata, Aaron N., Blakely, Collin M., McCoach, Caroline E., Bivona, Trever G., Wood, Kris C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516479/ https://www.ncbi.nlm.nih.gov/pubmed/35353542 http://dx.doi.org/10.1126/scitranslmed.abc7480 |
Ejemplares similares
-
Using Time-Varying Covariates in Multilevel Growth Models
por: McCoach, D. Betsy, et al.
Publicado: (2010) -
Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
por: Velazquez, Ana I., et al.
Publicado: (2020) -
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
por: Nichols, Robert J., et al.
Publicado: (2018) -
Testing for intersectional measurement invariance with the alignment method: Evaluation of the 8‐item patient health questionnaire
por: Cintron, Dakota W., et al.
Publicado: (2023) -
EGFR targeted therapy resistance: current status, challenges, and future outlook
por: Bivona, Trever G.
Publicado: (2020)